Cargando…

Cure of Chronic Viral Infection and Virus-Induced Type 1 Diabetes by Neutralizing Antibodies

Mostrar otras versiones (1)

The use of neutralizing antibodies is one of the most successful methods to interfere with receptor–ligand interactions in vivo. In particular blockade of soluble inflammatory mediators or their corresponding cellular receptors was proven an effective way to regulate inflammation and/or prevent its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ejrnaes, Mette, von Herrath, Matthias G., Christen, Urs
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270746/ https://www.ncbi.nlm.nih.gov/pubmed/16603445 http://dx.doi.org/10.1080/17402520600579028

Ejemplares similares

Cure of Chronic Viral Infection and Virus-Induced Type 1 Diabetes by Neutralizing Antibodies
por: Ejrnaes, Mette, et al.
Publicado: (2006)

Retracted: Cure of Chronic Viral Infection and Virus-Induced Type 1 Diabetes by Neutralizing Antibodies
por: Journal of Immunology Research,
Publicado: (2016)

Resolution of a chronic viral infection after interleukin-10 receptor blockade
por: Ejrnaes, Mette, et al.
Publicado: (2006)

Can We Learn From Viruses How to Prevent Type 1 Diabetes?: The Role of Viral Infections in the Pathogenesis of Type 1 Diabetes and the Development of Novel Combination Therapies
por: von Herrath, Matthias
Publicado: (2009)

Viral Trigger for Type 1 Diabetes: Pros and Cons
por: Filippi, Christophe M., et al.
Publicado: (2008)

Potential viral pathogenic mechanism in human type 1 diabetes
por: Schneider, Darius A., et al.
Publicado: (2014)

Blockade but Not Overexpression of the Junctional Adhesion Molecule C Influences Virus-Induced Type 1 Diabetes in Mice
por: Christen, Selina, et al.
Publicado: (2013)

Functional Redundancy of CXCR3/CXCL10 Signaling in the Recruitment of Diabetogenic Cytotoxic T Lymphocytes to Pancreatic Islets in a Virally Induced Autoimmune Diabetes Model
por: Coppieters, Ken T., et al.
Publicado: (2013)

The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes
por: Coppieters, Ken, et al.
Publicado: (2018)

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
por: Peakman, Mark, et al.
Publicado: (2010)

The Type 1 Diabetes Signature: Hardwired to Trigger Inflammation?
por: Coppieters, Ken T., et al.
Publicado: (2014)

Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Optimizing the path from bench to bedside
por: Bresson, Damien, et al.
Publicado: (2009)

Immunosuppressive Mechanisms During Viral Infectious Diseases
por: Sarikonda, Ghanashyam, et al.
Publicado: (2010)

Recent advances in understanding Type 1 Diabetes
por: Christoffersson, Gustaf, et al.
Publicado: (2016)

A Deeper Look into Type 1 Diabetes – Imaging Immune Responses during Onset of Disease
por: Christoffersson, Gustaf, et al.
Publicado: (2016)

New Insights Into the Role of Autoreactive CD8 T Cells and Cytokines in Human Type 1 Diabetes
por: Bender, Christine, et al.
Publicado: (2021)

Current and future therapies for type 1 diabetes
por: von Scholten, Bernt Johan, et al.
Publicado: (2021)

Direct Infection of Dendritic Cells during Chronic Viral Infection Suppresses Antiviral T Cell Proliferation and Induces IL-10 Expression in CD4 T Cells
por: Baca Jones, Carmen, et al.
Publicado: (2014)

Non-antigenic and antigenic interventions in type 1 diabetes
por: Rydén, Anna KE, et al.
Publicado: (2013)

SIGNIFICANCE OF BIVALENCE OF ANTIBODY IN VIRAL NEUTRALIZATION
por: Rosenstein, Robert W., et al.
Publicado: (1971)

Antibody and complement-dependent viral neutralization
por: Cooper, Neil R., et al.
Publicado: (1979)

Preexisting Autoantibodies Predict Efficacy of Oral Insulin to Cure Autoimmune Diabetes in Combination With Anti-CD3
por: Mamchak, Alusha A., et al.
Publicado: (2012)

Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection
por: Holdener, Martin, et al.
Publicado: (2008)

Virus-induced autoimmune disease
por: Herrath, Matthias G von, et al.
Publicado: (1996)

Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
por: Pham, Minh N., et al.
Publicado: (2016)

Response to Comment on Rodriguez-Calvo et al. Increase in Pancreatic Proinsulin and Preservation of β-Cell Mass in Autoantibody-Positive Donors Prior to Type 1 Diabetes Onset. Diabetes 2017;66:1334–1345
por: Rodriguez-Calvo, Teresa, et al.
Publicado: (2017)

Viral infection prevents diabetes by inducing regulatory T cells through NKT cell–plasmacytoid dendritic cell interplay
por: Diana, Julien, et al.
Publicado: (2011)

Viral neutralization by antibody-imposed physical disruption
por: Zheng, Qingbing, et al.
Publicado: (2019)

To prescreen or not to prescreen for broadly neutralizing antibody sensitivity in HIV cure-related trials
por: Patel, Hursch, et al.
Publicado: (2023)

T-bet Controls Autoaggressive CD8 Lymphocyte Responses in Type 1 Diabetes
por: Juedes, Amy E., et al.
Publicado: (2004)

Trading off fiscal budget adherence and child protection
por: Cavalca, Petra Gram, et al.
Publicado: (2022)

Interference with pancreatic sympathetic signaling halts the onset of diabetes in mice
por: Christoffersson, Gustaf, et al.
Publicado: (2020)

TRANSITORY APPEARANCE OF TYPE 2 NEUTRALIZING ANTIBODY IN PATIENTS INFECTED WITH TYPE 1 POLIOMYELITIS VIRUS
por: Sabin, Albert B.
Publicado: (1952)

Defensins Potentiate a Neutralizing Antibody Response to Enteric Viral Infection
por: Gounder, Anshu P., et al.
Publicado: (2016)

Erratum. Increased Immune Cell Infiltration of the Exocrine Pancreas: A Possible Contribution to the Pathogenesis of Type 1 Diabetes. Diabetes 2014;63:3880–3890
por: Rodriguez-Calvo, Teresa, et al.
Publicado: (2016)

The healthy exocrine pancreas contains preproinsulin-specific CD8 T cells that attack islets in type 1 diabetes
por: Bender, Christine, et al.
Publicado: (2020)

Complete mapping of viral escape from neutralizing antibodies
por: Doud, Michael B., et al.
Publicado: (2017)

A Recombinant Avian Leukosis Virus Subgroup J for Directly Monitoring Viral Infection and the Selection of Neutralizing Antibodies
por: Wang, Qi, et al.
Publicado: (2014)

Increased Immune Cell Infiltration of the Exocrine Pancreas: A Possible Contribution to the Pathogenesis of Type 1 Diabetes
por: Rodriguez-Calvo, Teresa, et al.
Publicado: (2014)

Neutralizing Antibodies against Plasmodium falciparum Associated with Successful Cure after Drug Therapy
por: Goh, Yun Shan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rg7ho2b0a16mo80ov99t0vbf0k